Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis

45Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Advanced technology in molecular biology has provided us powerful tools for the diagnosis and treatment for cancer. We herein adopted a new methodology to identify a novel cancer/ testis (CT) antigen with high frequency of expression in colorectal cancer as follows: (a) combining laser microdissection and cDNA microarray was used to analyze the gene expression profile of colorectal cancer cells; (b) genes overexpressed in testis and underexpressed in normal colon epithelium were analyzed using cDNA microarray; and (c) the gene expression profile of colorectal cancer cells was compared with that of normal testis. Using this methodology, we selected 38 candidates for CT antigen. Among these genes, we identified a novel CT antigen, serine/threonine kinase 31 (STK31), which was previously reported as a gene expressed in spermatogonia. Reverse transcription-PCR analysis showed that STK31 gene expression levels in cancer samples were significantly higher (P < 0.0001) than those in normal samples. The STK31 gene was frequently expressed not only in colorectal cancer but also in gastric and esophageal cancer. Moreover, STK31 peptide was able to elicit specific CTLs and induced CTLs lysed either peptide-loading or endogenously STK31-expressing target cells. These results showed that the new methodology in this study facilitated identification of CT antigens and that STK31 may be a candidate for cancer immunotherapy against gastrointestinal cancer. ©2008 American Association for Cancer Research.

References Powered by Scopus

Cancer statistics, 2006

5608Citations
N/AReaders
Get full text

Minimum information about a microarray experiment (MIAME) - Toward standards for microarray data

3408Citations
N/AReaders
Get full text

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

3306Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Oncogenic cancer/testis antigens: Prime candidates for immunotherapy

259Citations
N/AReaders
Get full text

Prepubertal human spermatogonia and mouse gonocytes share conserved gene expression of germline stem cell regulatory molecules

174Citations
N/AReaders
Get full text

A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: A road map for the study of genes with potential clinical relevance

77Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yokoe, T., Tanaka, F., Mimori, K., Inoue, H., Ohmachi, T., Kusunoki, M., & Mori, M. (2008). Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis. Cancer Research, 68(4), 1074–1082. https://doi.org/10.1158/0008-5472.CAN-07-0964

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

66%

Professor / Associate Prof. 4

14%

Researcher 4

14%

Lecturer / Post doc 2

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 14

47%

Agricultural and Biological Sciences 8

27%

Biochemistry, Genetics and Molecular Bi... 6

20%

Pharmacology, Toxicology and Pharmaceut... 2

7%

Save time finding and organizing research with Mendeley

Sign up for free